Three sets of electrodiagnostic criteria for establishing primary demyelination in chronic polyneuropathy are evaluated. Sensitivity is assessed in 70 patients with clinically established chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The criteria use different abnormal values, one adjusts for the effects of axonal loss, while another relies only on conduction velocity. However, even when consideration is given to sufficient number of nerves tested, there is no significant difference (P = 0.37) in diagnostic sensitivity among them, with 48% to 64% of CIDP patients fulfilling criteria for primary demyelination. Specificity is assessed by applying the criteria to 47 patients with motor neuron disease and 63 patients with diabetic polyneuropathy. No patients meet any of the criteria. Further analysis shows that as sensitivity increases specificity decreases, because of overlapping distributions of nerve conduction abnormalities in these neuropathic disorders. A sensitivity of approximately 66% is a practical limit for electrodiagnostic criteria in CIDP.
T h e diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is made from the clinical history, physical examination, and laboratory tests. l 1 Measurement of nerve conduction is helpful because it permits electrodiagnostic assessment of demyelination, the primary underlying pathology. 11p20 Expected changes are slowed conduction velocity, abnormal temporal dispersion, and conduction block. l4 The wide range of normal values for these measures make it important to establish abnormal values which are reasonably predictive of primary demyelination. In early studies of CIDP, slowed motor nerve conduction velocity and subjective estimates of abnormal temporal dispersion were empha~ized.~.' 1*16220
In later studies, formal sets of criteria were proposed to establish electrodiagnostic evidence of primary demyelination which consider distal latency, conduction velocity, partial conduction block or abnormal temporal dispersion, and F-wave latency.
Three sets of criteria have been recently proposed for electrodiagnostic identification of patients with CIDP.1,334 They differ in several respects; they use different values to define abnormalities, 1 attempts to account for the effect of axonal loss on nerve conduction, while another considers only conduction velocity ( Table 1) . The sensitivity of these criteria for identifying CIDP has not been evaluated in a large group of patients, nor have the criteria been compared with each other. Furthermore, specificity (true negative rate) in identifying primary demyelination has not been established in groups of patients with neuropathic disorders in which demyelination is unexpected or is considered to be of secondary importance to axonal damage. 6 In this report, three sets of criteria are evaluated for sensitivity using nerve conduction data from patients with the clinical diagnosis of CIDP. Specificity is tested on nerve conduction data from patients with motor neuron disease (MND) and diabetic polyneuropathy (DP). Factors in the mea- surement of nerve conduction which influence sensitivity are identified, and evidence is presented for an upper limit of sensitivity which preserves reasonable specificity.
METHODS
Nerve conduction data were obtained from 3 groups of patients. (a) Seventy patients, who were actively followed in our clinic, fulfilled clinical criteria for idiopathic CIDP. Nerve conduction studies were performed us- 20.
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. ing conventional techniques.2 These included recording of the compound muscle action potential (CMAP) with surface disc electrodes. Proximal stimulation sites for the ulnar and peroneal nerves were below the elbow and fibular head, respectively. Skin temperature was maintained between 32" and 34°C with hot packs. When bilateral measurements were made on specific nerves, only measures from one side of the body were analyzed (the side with the greatest number of nerve studied).
Nerve conduction values were reviewed to determine if they exceeded abnormal limits listed in Table 1 for 3 sets of criteria, designated sets A3, B', and C4. A modification was made to the second criterion of set B. Because duration measurements of the negative component of the CMAP were not available for every patient, no distinction was made between partial conduction block and abnormal temporal dispersion with possible conduction block; the term "conduction blocklabnorma1 temporal dispersion" used in this report refers to measurements in which the proximal : distal CMAP ratio was lower than the limiting values listed in criteria sets A and B.
The number of abnormal nerve conduction values for each patient was tabulated to determine if the patient completely fulfilled requirements for primary demyelination. Abnormal values for individual measures were calculated as percentages of laboratory upper limits of normal (ULN) or lower limits of normal (LLN) values. The limits of normal were set at the range for values not normally distributed (tibia1 motor nerve distal latency and conduction velocity) or at 2 SD above or below normal mean values for normally distributed measures. The normal laboratory values were obtained from subjects of both genders, and whose ages ranged from the first to the seventh decades. The ULN and LLN are marked in Figure 1 .
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RESULTS
The age and gender distributions ( Table 2 ) are similar to those reported for CIDP and MND patient~.~"'
Sensitivity of Criteria A, B, and C for CIDP. Sensitivities (true positive rate) of each of the 3 criteria were determined using available nerve conduction data for each patient. Sets A, B, and C had sensitivities of 5076, 46%, and 43%, respectively, and differences in these rates were not statistically significant (P = 59) ( Table 3) . Not every testable motor nerve was evaluated in each patient so that failure to fulfill a set could possibly result from insufficient sampling. Exclusion of such patients and recalculation of sensitivity resulted in 64% of patients fulfilling criteria for set A, 60% for set B, and 48% for set C. The difference in proportions were not statistically significant (P = .37). The apparent increase in sensitivity may be an overestimate because not every untested nerve would be abnormal.
Comparison of the 3 Criteria. The three criteria differ from each other by using different abnormal values for individual measures of nerve conduction and by requiring different numbers of abnormal measures to meet full criteria ( Table 1) . The sensitivity of each set was studied by reviewing the data to determine (a) which individual nerve conduction measure was most frequently abnormal, and (b) which measure was most often abnormal in the required number of nerves (Table 4). For example, when the abnormal level for conduction velocity was 75% of the LLN, as in set A (Table l) , significantly more (P = .0001) individual nerves were abnormal than when the level was 70% of the LLN as in set C ( Table 4) . Similar findings were noted for F-wave latency, and significantly more (P = .0001) nerves were abnormal in set B (120% of ULN) compared with A (130% of ULN). In set B, F-wave latency was most frequently judged abnormal at 120% of the ULN because most nerves had a CMAP amplitude greater than 80% of the LLN (Table 1) . When the data were reviewed to see whether abnormalities occurred in 1 or 2 nerves, as re- quired by each set (Table l) , the sensitivity of indimonly fulfilled because it was required in 2 vidual measures changed ( Table 5 ) . For example, conduction blocWabnorma1 temporal dispersion was the most commonly fulfilled measure, in part because only 1 nerve was required to be abnormal in both sets A and B. On the other hand, although F waves were frequently abnormal in individual nerves in set B, this abnormality was less comnerves.
Specificity of Criteria A, B, and C in Other Neuropathic Disorders. Specificity (true negative rate) of the 3 sets was tested with nerve conduction data from patients with MND and DP, and no patients fulfill any set for primary demyelination ( Table 3) . 
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Fewer nerves were tested than in patients with CIDP, but when consideration was given for sufficient numbers tested, only 1 patient with DP could possibly fulfill set C. Several differences in nerve conduction abnormalities were noted between primary demyelinating and primary axonal disorders (Table 4) . First, abnormalities of conduction velocity, distal latency, and F-wave latency were uncommon in both MND and DP, but occurred frequently in CIDP. Second, conduction blocWabnorma1 temporal dispersion was the most common abnormal measure in MND and DP, but occurs significantly less frequently in MND and DP than in CIDP (P
< .0001 for each comparison).
Analysis of Different Criteria. Sensitivity of electrodiagnostic criteria can be increased by 3 methods. First, the required number of abnormal conduction measures can be reduced. This method was used in set C (Table l) , but sensitivity was only 43% when abnormal conduction velocity was required in 2 nerves (Table 3) . When abnormal conduction velocity was required in only 1 nerve (modified set C, Table l), sensitivity increased to 66% (Table 3) .
Second, all nerve conduction measures can be evaluated, but each given equal weight so that an abnormal measure in 1 nerve can be used to fulfill criterion. Using the abnormal values from set A, but modified, so that conduction velocity and distal latency criteria were fulfilled when abnormal in only 1 nerve (modified set A, Table l), sensitivity increased to 6676, while specificity was unchanged at 100% (Table 3) .
Third, abnormal values for each nerve conduction measure can be made less stringent, with a goal of achieving at least 75% sensitivity and 75% specificity for each measure. The distribution of nerve conduction values for each conduction measure revealed substantial overlap among the 3 disorders and with the normal range (Fig. 1) . Abnormal values, which include 75% of CIDP patients, were near the ULN and LLN for each measure, thereby potentially including normal subjects.
The values marking the 75th percentile for sensitivity for CIDP patients were also values which include up to 59% of patients with MND and DP. When values at the 75th percentile for individual nerve conduction measures were substituted for the values in sets A and B, overall sensitivity for CIDP patients rose to nearly loo%, but specificity fell to nearly 0%. This increase in sensitivity and decrease in specificity was due to the fact that multiple nerves, each with values at 75% sensitivity and 75% specificity, were tested in an individual patient. Although many combinations can be chosen of abnormal values, and numbers of abnormal measures required to fulfill all criteria, 66% sensitivity appeared to be a practical limit attainable without reducing specificity. This level of sensitivity can be achieved by requiring only a single abnormality in 1 nerve (modified set C), or less stringent abnormalities in several nerves (modified set A).
DISCUSSION
Evaluation of 3 electrodiagnostic criteria for establishing the diagnosis of demyelinating polyneuropathy indicates that sets A and B have similar sensitivity. The greater complexity of set B, based on the amplitude of the distal CMAP, does not appear to offer an advantage. This is found to occur for several reasons. The distal CMAP amplitude is below 80% of the LLN in 38% of tested nerves, Table 6 . Number of patients fulfilling individual nerve conduction criterions for electrodiagnostic evidence for primary demyelination. and for the majority of nerves, therefore, the abnormal values in set B are less stringent than those in set A in this group of CIDP patients (Table 5 ).
However, the 2 sets of values are sufficiently similar to include nearly equal percentages of patients for each measure ( Table 6 ). Set B requires abnormal F waves in 2 nerves, but permits the absence of an F wave after a suitable number of trials to count toward fulfillment (Table 1) . Although set A does not count an absent F wave as abnormal, it requires only one abnormal response, which results in no significant differences in the proportion of patients fulfilling this measure in sets A and B.
Increasing the sensitivity of the criteria proved difficult. While it is possible to calculate abnormal values which achieve 75% sensitivity for individual measures for CIDP patients, these values overlap conduction values from normal subjects and patients with primary axonal loss (Fig. l) . Substitution of these calculated abnormal values in sets A and B results in nearly 100% sensitivity, but much lower specificity with false inclusion of nearly 100% of patients with MND and DP.
Although the 3 criteria require a specific number of abnormal measures to achieve fulfillment, none addresses the question of how many motor nerves should be tested. There is a practical limit to the number of motor nerves accessible for testing, commonly the ulnar, median, peroneal, and tibia1 nerves. Bilateral measures of nerve conduction from the same nerve are highly correlated in normal subjects and in CIDP patients (Bromberg, unpublished observations) . Accordingly, to insure independent assessments, it is prudent to include data for a particular nerve from only 1 side of the body.
When nerves are unresponsive to electrical stimulation, they do not contribute to any criteria, but only 15% of nerves tested are unresponsive in this sample of CIDP patients. Although a number of patients fulfill criteria for primary demyelination when only 2 nerves are tested, it is reasonable to require testing of 4 motor nerve before concluding that a patient does not meet the criteria, with notation of the number of unresponsive nerves. In the same vein, an F-wave response should be considered absent only after a suitable number of trials, as required in set B.
It is difficult to compare the 48% to 66% sensitivity obtained in this sample of CIDP patients to other samples. Early studies relied on slowed conduction velocity only, and conduction data are frequently expressed in terms of group means.' ' , 2 0
In one series, only 67% of CIDP patients had slowed conduction velocity in a single motor nerve,4 and, in the current study group, 66% of patients fulfill this minimal requirement.
There are several reasons why sensitivity is not higher. Patients received their initial nerve conduction study at different stages in the course of their disease. l 1 The extent of demyelination and remyelination during the course of the polyneuropathy affects nerve conduction. In acute inflammatory demyelinating polyradiculoneuropathy (AIDP), which has a monophasic time course of demyelination, u p to 86% of patients fulfill a similar set of electrodiagnostic criteria at the peak of symptoms, but only 63% to 67% fulfill criteria during the early convalescent phase.2 This is a similar percentage to that seen in CIDP using the AIDP riter ria.^ Another factor is that the only commonly available measure of conduction over proximal nerve segments, where demyelination may be severe, is F wave latency. l 1 Partial conduction blocldabnormal temporal dispersion is a sensitive measure for detecting primary demyelination, and may occur to a reater degree in more proximal nerve segments!17
Recording responses over more proximal segments may be one method of increasing the likelihood of detecting this abnormality. This can be performed practically along the ulnar nerve by stimulating below and above the elbow, at the mid-arm, at the axilla, and at Erb's point. ' There are no false positive errors for the three criteria. DP was chosen as a difficult test of the criteria. Although pathological changes support axonal degeneration as the primary process and demyelination as a lesser process,6 electrodiagnostic features of DP include reduced CMAP amplitude, prolonged distal and F-wave latencies, and slowed conduction velocity. lo Specificity has also been demonstrated by the diagnosis of CIDP superimposed on DP when nerve conduction studies fulfill criteria for primary demyelination.8 All diabetic patients had symptomatic polyneuropathy of mild to moderate degree; all but 2 had abnormal spontaneous activity on needle electromyography, and many had absent evoked motor and sensory nerve responses.
MND was chosen because it is a motor neuronopathy with reduced CMAP, mildly prolonged distal latency, and slowed conduction velocity, presumably secondary to loss of large motor fiber^.^ The only abnormal measure encountered is conduction blocMabnormal temporal dispersion. Apparent conduction block can occur when there are few motor fibers remaining, and the motor units are enlarged; in this situation, normal temporal dispersion can reduce phase addition in the response recorded after stimulation at proximal sites.' Ten of 12 nerves showing block in patients with MND have low CMAP amplitude, and likely demonstrate apparent conduction block by this mechanism. Attention to conduction block is important because true conduction block may be the first diagnostic clue to a special form of multifocal demyelinating motor neuropathy which mimics clinical features of MND, but which is potentially treatable. 15, 19 In summary, the criteria currently proposed for demonstrating electrodiagnostic evidence for primary demyelination, while highly specific, are only moderately sensitive. With few changes in these criteria, the maximal sensitivity with adequate specificity appears to be about 66%. This can be achieved by requiring a single abnormal measure (conduction velocity) in 1 nerve (modified set C ) , or by requiring several different abnormal conduction measures (modified set A). There are arguments favoring use of criteria, which require greater numbers of abnormalities. First, they increase diagnostic confidence by excluding forms of hereditary neuropathies and focal entrapment neuropathies. Hereditary motor sensory neuropathy (type I) would commonly satisfy individual measures of distal latency, conduction velocity, and F-wave latency, but not abnormal conduction blocldabnormal temporal d i s p e r s i~n . '~, '~ A focal entrapment neuropathy could cause slow nerve conduction. Second, criteria requiring greater numbers of nerve abnormalities permit more detailed analysis of the effects of therapy. For example, reduction of conduction block or abnormal temporal dispersion, and improvement in distal latency, may occur before improvement in conduction velocity during therapy," and this would be missed if only the latter were being monitored.
Third, nerve conduction studies, as routinely applied to distal limb segments, may underestimate the extent of the demyelinating process." Since conduction blocldabnormal temporal dispersion is a frequently abnormal measure, more extensive testing for this abnormality may increase sensitivity.
Although nerve conduction abnormalities in CIDP appear to be distinct from those in neuropathic disorders without primary demyelination, the correct diagnosis of CIDP must rely upon assessment of all clinical data, and use of a full set of clinical and laboratory inclusion criteria, such as recently proposed lg4 will be helpful.
